Robbert Jan Kok

Title: Robbert Jan Kok: Innovator in Cell-Targeting Conjugates

Introduction

Robbert Jan Kok is a notable inventor based in Nieuwegein, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for preparing cell-targeting conjugates. His innovative work has the potential to enhance therapeutic and diagnostic applications.

Latest Patents

Robbert Jan Kok holds a patent for a "Method for preparing cell targeting conjugates, and the complexes obtained." This patent outlines a method for coupling at least one functional moiety, such as a therapeutic compound, diagnostic compound, or chelating agent, to a targeting moiety. The patent also describes the cell-targeting conjugates that can be obtained through this method, as well as pharmaceutical compositions that include these conjugates. He has 1 patent to his name.

Career Highlights

Robbert Jan Kok is associated with Linxis B.V., where he applies his expertise in the development of innovative pharmaceutical solutions. His work focuses on enhancing the efficacy of drug delivery systems through targeted approaches.

Collaborations

Robbert has collaborated with notable colleagues, including Hendrik Jan Houthoff and Augustinus A M S Van Dongen. These collaborations have contributed to the advancement of research in the field of cell-targeting technologies.

Conclusion

Robbert Jan Kok's contributions to the field of pharmaceuticals through his innovative methods for preparing cell-targeting conjugates highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic and diagnostic applications.